Home News

First quarter 2019 results presentation

Operating income, growth figures, profitability and how our products have behaved

Wed, 08/05/2019 - 12:15 0 min
Download related document
No votes yet
 
Related
2018 full year results presentation
0 min
26/02/2019
ROVI reports operating revenue growth of 10%, underpinned by the behaviour of...
The operating revenue of Laboratorios Farmacéuticos ROVI increased by 10% to 303.2 million euros in 2018, driven mainly by the strength of...
5 min
26/02/2019
ROVI acquires rights to Dexchlorpheniramine Maleate in the Spanish and French...
Laboratorios Farmacéuticos Rovi, S.A. (“ROVI”) has reached an agreement with a subsidiary of MSD (“MSD”) whereby ROVI acquires certain...
2 min
15/02/2019